Bio Path reported $-0.07 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Baxter International USD 0.36 0.08 Mar/2026
Bio Path USD -0.07 0.48 Sep/2025
Cipla INR 6.86 8.34 Mar/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.16 0.02 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025